{"id":"https://openalex.org/W2018372149","doi":"https://doi.org/10.1517/13543776.2014.989214","title":"Imidazo[1,2-a]pyridines as cholesterol 24-hydroxylase (CYP46A1) inhibitors: a patent evaluation (WO2014061676)","display_name":"Imidazo[1,2-a]pyridines as cholesterol 24-hydroxylase (CYP46A1) inhibitors: a patent evaluation (WO2014061676)","publication_year":2014,"publication_date":"2014-12-16","ids":{"openalex":"https://openalex.org/W2018372149","doi":"https://doi.org/10.1517/13543776.2014.989214","mag":"2018372149","pmid":"https://pubmed.ncbi.nlm.nih.gov/25514969"},"language":"en","primary_location":{"id":"doi:10.1517/13543776.2014.989214","doi":"https://doi.org/10.1517/13543776.2014.989214","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543776.2014.989214","pdf_url":null,"source":{"id":"https://openalex.org/S3784663","display_name":"Expert Opinion on Therapeutic Patents","issn_l":"1354-3776","issn":["1354-3776","1744-7674"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Therapeutic Patents","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025266325","display_name":"Yoshikazu Uto","orcid":"https://orcid.org/0000-0002-5170-3297","observed_orcids":["https://orcid.org/0000-0002-5170-3297"]},"institutions":[{"id":"https://openalex.org/I4210104626","display_name":"Daiichi-Sankyo (Japan)","ror":"https://ror.org/027y26122","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104626"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Yoshikazu Uto","raw_affiliation_strings":["Daiichi Sankyo Co., Ltd., Venture Science Laboratories , 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710 , Japan +813 3492 3131 ; +813 5436 8563 ; uto.yoshikazu.pw@daiichisankyo.co.jp","+813 5436 8563","Daiichi Sankyo Co., Ltd., Venture Science Laboratories, 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan +813 3492 3131"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Daiichi Sankyo Co., Ltd., Venture Science Laboratories , 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710 , Japan +813 3492 3131 ; +813 5436 8563 ; uto.yoshikazu.pw@daiichisankyo.co.jp","institution_ids":["https://openalex.org/I4210104626"]},{"raw_affiliation_string":"+813 5436 8563","institution_ids":[]},{"raw_affiliation_string":"Daiichi Sankyo Co., Ltd., Venture Science Laboratories, 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan +813 3492 3131","institution_ids":["https://openalex.org/I4210104626"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5025266325"],"corresponding_institution_ids":["https://openalex.org/I4210104626"],"apc_list":null,"apc_paid":null,"fwci":0.6648,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.71297532,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"25","issue":"3","first_page":"373","last_page":"377"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.5576000213623047,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.5576000213623047,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.2874000072479248,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.06319999694824219,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/imidazo-1-2-a-pyridines","display_name":"imidazo[1,2-a]pyridines","score":0.984000027179718},{"id":"https://openalex.org/keywords/cholesterol-24-hydroxylase","display_name":"cholesterol 24-hydroxylase","score":0.9940000176429749},{"id":"https://openalex.org/keywords/neurodegenerative-diseases","display_name":"neurodegenerative diseases","score":0.6290000081062317},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9990000128746033},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":1.0},{"id":"https://openalex.org/keywords/pharmacophore","display_name":"pharmacophore","score":0.7239999771118164},{"id":"https://openalex.org/keywords/patent-analysis","display_name":"patent analysis","score":0.6779999732971191}],"concepts":[{"id":"https://openalex.org/C56173144","wikidata":"https://www.wikidata.org/wiki/Q1539893","display_name":"Pharmacophore","level":2,"score":0.8306892514228821},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5898903608322144},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4860432744026184},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.4262010157108307},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.42162439227104187},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.339114248752594},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.33669477701187134},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3004544973373413},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2095544934272766}],"mesh":[{"descriptor_ui":"D000072556","descriptor_name":"Cholesterol 24-Hydroxylase","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010330","descriptor_name":"Patents as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013250","descriptor_name":"Steroid Hydroxylases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D019636","descriptor_name":"Neurodegenerative Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D019636","descriptor_name":"Neurodegenerative Diseases","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D065607","descriptor_name":"Cytochrome P-450 Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D065607","descriptor_name":"Cytochrome P-450 Enzyme Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1517/13543776.2014.989214","doi":"https://doi.org/10.1517/13543776.2014.989214","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543776.2014.989214","pdf_url":null,"source":{"id":"https://openalex.org/S3784663","display_name":"Expert Opinion on Therapeutic Patents","issn_l":"1354-3776","issn":["1354-3776","1744-7674"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Therapeutic Patents","raw_type":"journal-article"},{"id":"pmid:25514969","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25514969","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on therapeutic patents","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W1925239524","https://openalex.org/W1972490547","https://openalex.org/W1976928449","https://openalex.org/W1979556755","https://openalex.org/W1986241538","https://openalex.org/W1992465104","https://openalex.org/W1997811388","https://openalex.org/W2003966687","https://openalex.org/W2008823657","https://openalex.org/W2010508749","https://openalex.org/W2030566485","https://openalex.org/W2037416738","https://openalex.org/W2045779796","https://openalex.org/W2049430814","https://openalex.org/W2049982743","https://openalex.org/W2063962685","https://openalex.org/W2069478110","https://openalex.org/W2079640733","https://openalex.org/W2091588620","https://openalex.org/W2098187188","https://openalex.org/W2111119128","https://openalex.org/W2127943842","https://openalex.org/W2128990583","https://openalex.org/W2143827549","https://openalex.org/W2166857331","https://openalex.org/W2171492635","https://openalex.org/W4237615604"],"related_works":["https://openalex.org/W3009372785","https://openalex.org/W3117157359","https://openalex.org/W4309347363","https://openalex.org/W4411196965","https://openalex.org/W4319333389","https://openalex.org/W4409225047","https://openalex.org/W7125895457","https://openalex.org/W4213335805","https://openalex.org/W2017396859","https://openalex.org/W2995226570"],"abstract_inverted_index":{"A":[0],"series":[1],"of":[2,19],"imidazo[1,2-a]pyridine":[3],"analogs":[4],"that":[5,45],"effectively":[6],"inhibit":[7],"cholesterol":[8],"24-hydroxylase":[9],"(CYP46A1)":[10],"was":[11],"reported":[12],"in":[13,36,53],"WO2014061676.":[14],"The":[15],"treatment":[16],"or":[17],"prophylaxis":[18],"neurodegenerative":[20],"disorders,":[21],"such":[22],"as":[23],"Alzheimer's":[24],"disease":[25],"and":[26],"Parkinson's":[27],"disease,":[28],"by":[29,58],"these":[30],"novel":[31,43],"CYP46A1":[32],"inhibitors":[33],"is":[34,46],"claimed":[35],"the":[37,54],"patent.":[38],"These":[39],"compounds":[40],"represent":[41],"a":[42],"pharmacophore":[44],"different":[47],"from":[48],"other":[49],"structural":[50],"motifs":[51],"described":[52],"prior":[55],"patent":[56],"publications":[57],"Takeda":[59],"Pharmaceutical":[60],"Company":[61],"Ltd.":[62]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}